[HTML][HTML] Gene expression profiling in melanoma: A view from the clinic

SM Bollard, C Casalou, SM Potter - Cancer Treatment and Research …, 2021 - Elsevier
The treatment of Melanoma, one of the most aggressive human malignancies, has been
revolutionised by the advent of novel targeted and immuno-therapies. However, methods …

β3 integrin immunohistochemistry as a method to predict sentinel lymph node status in patients with primary cutaneous melanoma

E Quattrocchi, S Sominidi‐Damodaran… - International journal …, 2020 - Wiley Online Library
Background Integrins are heterodimeric proteins composed of noncovalently linked ɑ and β
subunits which are essential for a wide range of normal physiology and also play prominent …

[HTML][HTML] Clinical evaluation of the clinicopathologic and gene expression profile (CP-GEP) in patients with melanoma eligible for sentinel lymph node biopsy: A …

RC Stassen, EEAP Mulder, AL Mooyaart… - European Journal of …, 2023 - Elsevier
Sentinel lymph node biopsy (SLNB) is recommended for patients with> pT1b cutaneous
melanoma, and should be considered and discussed with patients diagnosed with pT1b …

Predictive Biomarkers of Melanoma

A Hanly, F Gibson, RM Alani - Melanoma in Clinical Practice, 2021 - Springer
While the development of targeted and immunotherapies for malignant melanoma has
dramatically improved patient outcomes, there remains a need for biomarkers to aid in the …

Management of Transected Invasive Melanoma: A Single Institution Retrospective Review

JR Duncan, LL Beal, A Daugherty, C Elston… - Dermatologic …, 2022 - journals.lww.com
BACKGROUND Deep transection of invasive melanoma precludes accurate measurement
of Breslow depth, which may affect tumor staging. OBJECTIVE To determine the frequency …

[PDF][PDF] Prognostic Gene Expression Profiling in Cutaneous Melanoma

D Grossman, N Okwundu, EK Bartlett, MA Marchetti… - academia.edu
IMPORTANCE—Use of prognostic gene expression profile (GEP) testing in cutaneous
melanoma (CM) is rising despite a lack of endorsement as standard of care. OBJECTIVE …

[HTML][HTML] Considerations for adjuvant immunotherapy in stage II melanoma: KEYNOTE-716 and beyond

LN Chen, RD Carvajal - Annals of Translational Medicine, 2023 - ncbi.nlm.nih.gov
© Annals of Translational Medicine. All rights reserved. Ann Transl Med 2023; 11 (10): 368|
https://dx. doi. org/10.21037/atm-23-839 confidence interval crosses the threshold of 1 in …

[PDF][PDF] Towards a tailored therapeutic approach for vulvar cancer patients

KE Kortekaas - 2021 - scholarlypublications …
Objective High T cell infiltration in vulvar squamous cell carcinoma (VSCC) is associated
with favorable clinical outcome across molecular subtypes. Here, a more in-depth …

[HTML][HTML] Primary cilia: putting a sensor on the underlying melanocytic tumor cell state

UE Lang - Melanoma Management, 2020 - Taylor & Francis
Melanocytic neoplasms constitute some of the most challenging histopathologic entities in
pathology and trigger high levels of diagnostic uncertainty among general practice …

[HTML][HTML] 20/20 in 2020: seeking clarity on the management of stage III melanoma in a rapidly changing treatment environment

S Chandrasekaran, DH Lawson - Annals of Translational Medicine, 2020 - ncbi.nlm.nih.gov
Clinical management of cutaneous melanoma, especially resectable stage III disease, has
rapidly evolved over the past decade, and critical to developing an accurate treatment plan …